The efficacy and safety of amisulpride in the treatment of acute exacerbation patients with schizophrenia

阿米必利 临床全球印象 阳性与阴性症状量表 恶化 耐受性 医学 精神分裂症(面向对象编程) 内科学 评定量表 简明精神病评定量表 不利影响 安慰剂 精神科 抗精神病药 心理学 精神病 发展心理学 替代医学 病理
作者
Yunlong Tan,Zheng Lu,Chuan Shi,Jian-xiong Fan,Mou-ni Tang,Yi Zheng,Juan Li,Song Chen,Xin Yu
出处
期刊:Chin J Psychiatry 卷期号:51 (2): 113-117 被引量:1
标识
DOI:10.3760/cma.j.issn.1006-7884.2018.02.007
摘要

Objective To evaluate the efficacy and safety of amisulpride in acute exacerbation patients with schizophrenia. Methods In this study, one hundred and forty-four acute episode patients with schizophrenia, qualifyed with the International Classification of Diseases 10th revision, were enrolled. All patients received monotherapy of amisulpride for 8 weeks. The initial dose of amisulpride was 200 mg/d, and the dose was flexible during the 8 weeks according to the investigator judgement based upon symptoms and tolerability. Recommended therapeutic dose was 800 mg/d and maximum dose was 1 200 mg/d. The Positive and Negative Syndrome Scale (PANSS) was applied at the baseline and the 2nd, 4th, 8th week.The Clinical Global Impression Scale-Severity and Improvement (CGI-S, CGI-I) and the Personal and Social performance Scale (PSP) were adopted at the baseline and endpoint of treatment. The safety was evaluated by the Udvalg for Kliniske Undersogeser Side Effect Rating Scale, laboratory tests and electrocardiogram. The efficacy and safety were analyzed by using perprotocol and safety sets respectively. Results One hundred and thirty two patients completed this trial,and 12 patients dropped out during the study. After 8-week treatment, the positive scores (22.0±6.6 vs. 10.0±3.8) , negative scores (22.7±7.7 vs. 13.9±6.8) , general psychopathology scores (41.6±9.0 vs. 25.1±7.4) and the total scores (86.5±16.0 vs. 49.0±16.0) of PANSS were significantly improved (P<0.01) ; 77.3% patients had symptoms reduced in PANSS total scores by at least 50%, and the result was accordant to significant CGI-I improvement in 75.8% patients. Besides these, the PANSS response rate was significantly higher in positive scores than in negative scores (χ2=9.52, P<0.01). PSP was also significantly improved after 8-week treatment (t=18.10, P<0.01). The most popular side effects were extrapyramidal symptoms(29.2%) and hyperprolactinemia(23.6%). Conclusions Amisulpride is effective in treating psychopathological symptoms of acute exacerbations patients with schizophrenia, the most frequent side effects are seen in extrapyramidal symptoms and hyperprolactinemia. Key words: Schizophrenia; Safety; Treatment outcome; Amisulpride
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
活力以冬完成签到,获得积分10
2秒前
开朗含海完成签到,获得积分10
2秒前
Heby完成签到 ,获得积分10
5秒前
amiee发布了新的文献求助10
8秒前
酷炫蛋挞完成签到 ,获得积分10
10秒前
tough_cookie完成签到 ,获得积分10
10秒前
求知小生完成签到 ,获得积分10
11秒前
14秒前
前方的菜鸟完成签到 ,获得积分10
14秒前
花花子完成签到 ,获得积分10
15秒前
syvshc的应助被科研通管家采纳,获得10
16秒前
cssc完成签到,获得积分10
16秒前
arniu2008的应助被科研通管家采纳,获得20
16秒前
Owen的应助被科研通管家采纳,获得10
16秒前
懒猫完成签到,获得积分10
16秒前
鹏liu发布了新的文献求助10
19秒前
凌泉完成签到 ,获得积分10
20秒前
英姑的应助被shally采纳,获得10
23秒前
29秒前
淡然雅彤完成签到,获得积分10
31秒前
画龙点睛完成签到 ,获得积分10
32秒前
shally发布了新的文献求助10
34秒前
虚幻烤鸡完成签到,获得积分10
55秒前
梦瑶完成签到 ,获得积分10
55秒前
ziqizhou完成签到 ,获得积分10
57秒前
Firewoods完成签到 ,获得积分10
58秒前
科研人完成签到 ,获得积分10
58秒前
Kevin发布了新的文献求助200
1分钟前
如意的晓槐完成签到 ,获得积分10
1分钟前
内向小霜完成签到 ,获得积分10
1分钟前
烟花的应助被shally采纳,获得10
1分钟前
1分钟前
lllll完成签到 ,获得积分10
1分钟前
1分钟前
范yx发布了新的文献求助10
1分钟前
Eric完成签到,获得积分10
1分钟前
陈烨完成签到,获得积分10
1分钟前
侯子完成签到 ,获得积分10
1分钟前
shally发布了新的文献求助10
1分钟前
ninini完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185502
求助须知:如何正确求助?哪些是违规求助? 9574220
关于积分的说明 21834553
捐赠科研通 7783121
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558949
邀请新用户注册赠送积分活动 2481357